-
Drug overdose deaths are plummeting in the U.S. in ways never seen before. Experts worry new, toxic "synthetic" street drugs could derail the recovery.
-
Firms like Function Health and Oura market regular blood tests to people wanting to take their health into their own hands. The process often raises more questions for patients than it can answer.
-
An Israeli whose parents were killed on Oct. 7, 2023, and a Palestinian whose brother died from injuries in Israeli custody say they've become like brothers. Their new book is The Future Is Peace: A Shared Journey Across the Holy Land.
-
The prime minister announced new tax cuts to try to end the crisis that began after the U.S.-Israel war on Iran led to the closure of the Strait of Hormuz. The government could face a no-confidence vote over its response to the fuel protests.
-
Websites like youraislopbores.me have become playgrounds for people looking for light relief in a bot-heavy world.
-
With Virginia on board, the National Popular Vote Compact is now enacted in states worth 222 electoral votes. Here's what that means.
An official briefed on Israel's strategy for the talks described Tuesday's meeting as "preparatory" and aimed at laying out a framework for future negotiations.
-
Local TV giant Nexstar's $6.2 billion deal to acquire rival Tegna won speedy approval from Trump administration regulators. But it faces a tough challenge from a pair of antitrust lawsuits.
-
Section 702 of the Foreign Intelligence Surveillance Act is responsible for a huge share of intel collected by the U.S. Lawmakers and civil liberties advocates are worried it enables warrantless spying on U.S. citizens.
-
Diplomats from Israel and Lebanon will meet in Washington for rare direct talks.
-
President Trump has now deleted a controversial image that he claims wasn't a depiction of him as Jesus, but rather a doctor.
-
NPR speaks with Father James Martin, a Jesuit priest and author, about how Catholics are reacting to President Trump's recent criticism of Pope Leo.